Our R&D Capabilities
Process and Pharma Research
Our process research team is focused on developing patentable non-infringing processes for the company's operations in the regulated markets
The pharma research division covers both the antibiotic and non-antibiotic segments with specific departments for the domestic markets, other emerging markets and regulated markets. A specialized veterinary formulations program is also underway.
Pre-Clinical Research
Our pre-clinical facility (PCF) undertakes a wide range of studies, including regulatory toxicity – which are required for filing Investigational New Drug (IND) applications. A number of new screening facilities and biological evaluation models have been set up to support the drug discovery and development process.
A wide range of animal toxicology, microbiology and pharmacology studies are also undertaken to confirm the safety and efficacy of molecules. The facility is registered with the committee for the Purpose of Control and Supervision of Experiment on Animals (CPCSEA), Ministry of Environment & Forests and the Government of India. Additionally, an Institutional Animal Ethics Committee (IAEC) monitors our research for issues related to animal welfare and experimentation. Work quality standards are in compliance with US Food Drug Administration (US FDA) and the Organization for Economic Co-operation Development (OECD) principles of Good Laboratory Practice (GLP).
New Drug Discovery
Pioneering research to devise newer strategies for effectively delivering the drugs in the body or improvise the existing technologies to enhance their efficiency is the need of the hour. The ever improving delivery systems are not only beneficial to the patients as they are less cumbersome and easy to abide by but also reduce the complications associated with the induction of the drug in the body.
At Asctel Pharmaceuticals, we focus on developing novel drug delivery systems (NDDS) for select anti-infective molecules. A few platform and product specific technologies with six prototype formulations have been successfully developed.
Areas of NDDS Research
- Drug specific
- Platform technologies
- Disease conditions
Biotech Research
Our biotech research is focused on replacing existing chemical methods of manufacturing various intermediates, with fermentation and enzymatic based transformations to improve environmental safety.
Capabilities include:
- PCR and Directed evolution of proteins
- Gene cloning
- Protein expression and purification
- High-throughput screening
- Development of assays for proteins in the cephalosporin pathway